Gonadotropin-releasing hormone agonist

Results: 55



#Item
1Microsoft Word - DSU Degarelix FINAL sent to NICE

Microsoft Word - DSU Degarelix FINAL sent to NICE

Add to Reading List

Source URL: www.nicedsu.org.uk

Language: English - Date: 2015-06-17 10:44:39
2Microsoft Word - crt-uspi-mk8761-soi-1312r003.doc

Microsoft Word - crt-uspi-mk8761-soi-1312r003.doc

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2015-03-26 19:23:33
3ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2015-01-22 11:10:22
4The effects of male age on sperm analysis by motile sperm organelle morphology examination (MSOME)

The effects of male age on sperm analysis by motile sperm organelle morphology examination (MSOME)

Add to Reading List

Source URL: www.rbej.com

Language: English
5Kwartaalbericht 3e kwartaaldecember 2002  Contents

Kwartaalbericht 3e kwartaaldecember 2002 Contents

Add to Reading List

Source URL: www.lareb.nl

Language: English
6Vol.49, No.2 February[removed]Editorial Drug-induced Skin Reactions Yutaka Narisawa ..........................................................................................................................................

Vol.49, No.2 February[removed]Editorial Drug-induced Skin Reactions Yutaka Narisawa ..........................................................................................................................................

Add to Reading List

Source URL: www.med.or.jp

Language: English - Date: 2009-08-03 20:57:42
7AUSTRALIAN PESTICIDES & VETERINARY MEDICINES AUTHORITY Application Summary for Application No[removed]Application Details: Product Name:

AUSTRALIAN PESTICIDES & VETERINARY MEDICINES AUTHORITY Application Summary for Application No[removed]Application Details: Product Name:

Add to Reading List

Source URL: archive.apvma.gov.au

Language: English - Date: 2014-08-05 03:10:00
8[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX® (goserelin acetate

[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX® (goserelin acetate

Add to Reading List

Source URL: www1.astrazeneca-us.com

Language: English - Date: 2013-08-05 20:44:27
9HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIGARD safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) suspensio

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIGARD safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) suspensio

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-10-14 16:30:23
10HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX® (goserelin acetate implant)

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX® (goserelin acetate implant)

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-10-08 15:09:50